Literature DB >> 24038295

Atypical blood and bone marrow lymphocytes in ALK-positive anaplastic T-cell lymphoma: important lessons.

A J Mahdi1, N Elmusharaf, H Osman, I Thompson.   

Abstract

A 42-year-old man presented with a short history of fever, significant weight loss and bilateral neck swelling. A CT scan revealed widespread lymphadenopathy and hepatosplenomegaly. Lymph node morphology and immunohistochemistry confirmed a diagnosis of anaplastic lymphoma kinase (ALK)-positive anaplastic T-cell non-Hodgkin's lymphoma. Both the peripheral blood (PB) and bone marrow (BM) revealed atypical lymphocytes with cleaved nuclei, vacuolation and granulation, suggestive of disease involvement at both sites. However, BM and PB immunophenotyping and immunohistochemistry did not reveal typical markers (ALK and CD30) at either site. All features resolved with a short remission after conventional chemotherapy. Despite salvage chemotherapy and an autologous stem cell transplant, a relapse of the PB and BM features with stable radiological findings was noted. Rapid decline followed with pancytopenia resulting in death 12 months after the initial diagnosis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24038295      PMCID: PMC3794272          DOI: 10.1136/bcr-2013-200982

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  3 in total

Review 1.  Anaplastic large cell lymphoma, ALK-positive.

Authors:  Andrés J M Ferreri; Silvia Govi; Stefano A Pileri; Kerry J Savage
Journal:  Crit Rev Oncol Hematol       Date:  2012-03-21       Impact factor: 6.312

Review 2.  ALK-positive anaplastic large cell lymphoma with leukemic peripheral blood involvement is a clinicopathologic entity with an unfavorable prognosis. Report of three cases and review of the literature.

Authors:  Mihaela Onciu; Frederick G Behm; Susana C Raimondi; Sheila Moore; Emma L Harwood; Ching-Hon Pui; John T Sandlund
Journal:  Am J Clin Pathol       Date:  2003-10       Impact factor: 2.493

3.  Prognostic significance of circulating tumor cells in bone marrow or peripheral blood as detected by qualitative and quantitative PCR in pediatric NPM-ALK-positive anaplastic large-cell lymphoma.

Authors:  Christine Damm-Welk; Kerstin Busch; Birgit Burkhardt; Jutta Schieferstein; Susanne Viehmann; Ilske Oschlies; Wolfram Klapper; Martin Zimmermann; Jochen Harbott; Alfred Reiter; Willi Woessmann
Journal:  Blood       Date:  2007-03-28       Impact factor: 22.113

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.